Pharmacopeia to Request a Hearing With NASDAQ Following Receipt of Notice of Non-Compliance
07 nov. 2008 16h00 HE
|
Pharmacopeia, Inc.
PRINCETON, N.J., Nov. 7, 2008 (GLOBE NEWSWIRE) -- Pharmacopeia (Nasdaq:PCOP) today announced that it intends to request a hearing before a NASDAQ Listing Qualifications Panel ("Panel") to present a...
Pharmacopeia Announces Third Quarter 2008 Financial Results
06 nov. 2008 16h00 HE
|
Pharmacopeia, Inc.
PRINCETON, N.J., Nov. 6, 2008 (GLOBE NEWSWIRE) -- Pharmacopeia (Nasdaq:PCOP) today announced results for the quarter ended September 30, 2008.
Recent company developments have included the...
Ligand and Pharmacopeia to Present at the Rodman & Renshaw 10th Annual Healthcare Conference
04 nov. 2008 07h30 HE
|
Pharmacopeia, Inc.
PRINCETON, N.J., Nov. 4, 2008 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq:LGND) and Pharmacopeia (Nasdaq:PCOP), an innovator in the discovery and development of novel small...
Ligand and Pharmacopeia to Present At the Oppenheimer 19th Annual Healthcare Conference
28 oct. 2008 16h00 HE
|
Pharmacopeia, Inc.
PRINCETON, N.J., Oct. 28, 2008 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq:LGND) and Pharmacopeia (Nasdaq:PCOP), an innovator in the discovery and development of novel small...
Pharmacopeia Receives Notification From NASDAQ
03 oct. 2008 07h30 HE
|
Pharmacopeia, Inc.
PRINCETON, N.J., Oct. 3, 2008 (GLOBE NEWSWIRE) -- Pharmacopeia (Nasdaq:PCOP), an innovator in the discovery and development of novel small molecule therapeutics, today announced it received a notice...
Ligand to Acquire Pharmacopeia for Stock and Contingent Value Rights
24 sept. 2008 18h00 HE
|
Pharmacopeia, Inc.
Acquisition Would Result in Well Capitalized Company
With Robust Royalty Assets and Broad Research Pipeline
Conference Call Today at 5:30p.m. Eastern
SAN...
Pharmacopeia and GlaxoSmithKline Collaboration Identifies Sixth Lead Compound
16 sept. 2008 07h30 HE
|
Pharmacopeia, Inc.
PRINCETON, N.J., Sept. 16, 2008 (GLOBE NEWSWIRE) -- Pharmacopeia (Nasdaq:PCOP), an innovator in the discovery and development of novel small molecule therapeutics, announced today that it has...
Pharmacopeia Announces Further Reductions to Workforce
05 août 2008 07h30 HE
|
Pharmacopeia, Inc.
PRINCETON, N.J., Aug. 5, 2008 (PRIME NEWSWIRE) -- Pharmacopeia (Nasdaq:PCOP), an innovator in the discovery and development of novel small molecule therapeutics, has implemented the restructuring...
Pharmacopeia Announces Second Quarter 2008 Financial Results
31 juil. 2008 16h00 HE
|
Pharmacopeia, Inc.
PRINCETON, N.J., July 31, 2008 (PRIME NEWSWIRE) -- Pharmacopeia (Nasdaq:PCOP) today announced results for the quarter ended June 30, 2008 and further plans related to the clinical development of...
Pharmacopeia to Present At the Canaccord Adams 28th Annual Global Growth Conference
30 juil. 2008 07h30 HE
|
Pharmacopeia, Inc.
PRINCETON, N.J., July 30, 2008 (PRIME NEWSWIRE) -- Pharmacopeia (Nasdaq:PCOP), an innovator in the discovery and development of novel small molecule therapeutics, today announced that Brian M. Posner,...